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Reducing Child Mortality in the Last Mile: Experimental 
Evidence on Community Health Promoters in Uganda†
By Martina Björkman Nyqvist, Andrea Guariso, 
Jakob Svensson, and David  Yanagizawa-Drott*
The delivery of basic health products and services remains abysmal 
in many parts of the world where child mortality is high. This paper 
shows the results from a  large-scale randomized evaluation of a novel 
approach to health care delivery. In randomly selected villages, a 
sales agent was locally recruited and incentivized to conduct home 
visits, educate households on essential health behaviors, provide 
medical advice and referrals, and sell preventive and curative health 
products. Results after 3 years show substantial health impact:  under 
5-years child mortality was reduced by 27 percent at an estimated 
average cost of $68 per  life-year saved. (JEL I12, I18, J13, O15, O18)
Despite significant reductions in child and infant mortality over the last few decades, about 1 in 13 children in  sub-Saharan Africa still die before his or 
her fifth birthday (WHO 2017). Many, if not most, of these deaths can be avoided 
through simple preventative care and through simple, low cost treatments delivered 
at home. This means that an effective response to reduce child deaths is not out of 
reach. While health outcomes can be tied to a host of factors, both on the demand 
and supply side, there is limited evidence on effective and scalable solutions to the 
* Björkman Nyqvist: Department of Economics, Stockholm School of Economics, P.O. Box 6501, Sveavägen 65, 
SE- 113 83 Stockholm, and CEPR (email: Martina.Bjorkman.Nyqvist@hhs.se). Guariso: Department of Economics, 
Trinity College Dublin, Arts Building, Dublin 2, Ireland, and LICOS (email: guarisoa@tcd.ie). Svensson: Institute 
for International Economic Studies, Stockholm University, 106 91 Stockholm, Sweden, and CEPR (email: jakob.
svensson@iies.su.se). Yanagizawa-Drott: Department of Economics, University of Zurich, Schönberggasse 1, 8001 
Zurich, Switzerland (email: David_Yanagizawa-Drott@econ.uzh.ch). Benjamin Olken was coeditor for this article. 
An earlier version of this paper has been circulated under the title “Effect of a micro entrepreneur-based community 
health delivery program on under-five mortality in Uganda: a cluster-randomized controlled trial.” The trial was 
approved by the ethic committee of Fondazione IRCSS (D2291696), by the Harvard IRB (protocol P20141-101), by 
the Uganda National Council for Science and Technology (UNCST) (SS3195), and by the IRB Office of the Joint 
Clinical Research Center (JCRC) in Uganda. The trial was registered in the Pan African Clinical Trials Registry 
(PACTR201308000601715) and in the American Economic Association’s registry for randomized controlled trials 
(AEARCTR-0000530). We gratefully acknowledge two anonymous referees for many valuable comments and sug-
gestions. We appreciate comments on an earlier draft from May Sudhinaraset, Jenny Liu, Dominic Montagu, and 
Rebecca Weintraub. We thank Aletheia Donald and Charles Ntale for help during different phases of the evaluation, 
and the IPA-Uganda and its staff, specifically Jeff Alumai, Ezra Rwakazooba, Zahra Mansoor, Roselyn Mugide, and 
Douglas Kaziro. We thank Molly Christiansen, Joe Speicher, Chuck Slaughter at Living Goods, as well as Sharmin 
Sharif and a number of staff at the BRAC-Uganda office for insightful discussions over the years about the CHP 
program, and Anna Hakobyan and Amy Mayberry at the Children Investment Fund Foundation for support through-
out the study. Financial support from the Children Investment Fund Foundation and the Swedish Research Council 
(421-2013-1524 and 2016-05615) is greatly appreciated.
† Go to https://doi.org/10.1257/app.20170201 to visit the article page for additional materials and author 
disclosure statement(s) or to comment in the online discussion forum.
156 AMERICAN ECONOMIC JOURNAL: APPLIED ECONOMICS JULY 2019
problem (Dupas and Miguel 2016). In this paper, we focus on the role of delivery on 
basic health services and products to poor communities at the very end of the supply 
chain. How to combat child mortality in this space is arguably of first-order impor-
tance from a  policymaking perspective. On the one hand, evidence shows that when 
households get access to very basic health products and services, free of charge, 
mortality is substantially reduced (Kumar et al. 2008, Baqui et al. 2008). On the 
other hand, even if such solutions are socially desirable in the long run, in the short 
run they imply severe feasibility challenges in countries with poor state capacity in 
general, and service delivery capacity in particular.
In this paper, we study the impact of a novel community health delivery program. 
The program relies on “ Avon-like” networks of  door-to-door mobile Community 
Health Promoters (CHP), whose main activities resemble the standard activities of 
any community health worker: conduct home visits within their community, edu-
cate households on essential health behaviors, provide basic medical advice, and 
refer the more severe cases to the closest health center. On top of this, the CHPs 
make a modest income by selling a diverse basket of basic health goods, ranging 
from  anti-malaria drugs to soap and fortified foods. CHPs purchase these products 
directly from the nongovernmental organizations (NGOs) at wholesale price and 
earn a margin on each product sold. The idea is that these incentives on products, 
coupled with small financial incentives to encourage timely services, would not only 
move households down the demand curve but also motivate community health pro-
moters to actively provide basic health services to mothers, newborn, and children.1 
Thus, the CHPs operated as  micro-entrepreneurs with financial incentives to meet 
household demand and improve child health.
The program was randomized across 214 rural villages spread across Uganda and 
was fully operational in all treatment clusters, with at least 1 CHP locally recruited 
to the program, by the beginning of 2011.2 Our results after 3 years show that the 
program resulted in a substantial health impact: in treatment villages,  under 5-years 
child mortality was reduced by approximately 27 percent, infant (i.e., under 1-year) 
mortality by 33 percent, and neonatal (i.e., under 1-month) mortality by 28 percent, 
compared to control villages that did not receive the program.
While the evidence shows that households in treatment villages were signifi-
cantly more likely to use products sold by the CHPs, including  life-saving medical 
products such as insecticide treated bed nets and oral  rehydration salts for treat-
ing diarrhea, we also provide suggestive evidence that the effects were not simply 
driven by access to cheaper, high quality medicines and health products. In particu-
lar, we document large increases in a number of maternal, newborn, and child health 
services, including  follow-up visits and advice to seek professional medical care, in 
the treatment relative to the control group. We also show that households in the treat-
ment group have better knowledge of basic health issues compared to households in 
the control villages. While we cannot rule out that these  non-incentivized services 
1 The CHPs received small  performance-based incentives to encourage registering of pregnant women and visits 
of newborns ( ∼ $0.65 per registration/newborn visit). 
2 The rollout of the CHP program, including the trial clusters, was overseen by an advisory board including 
individuals with expertise in international public health and health service research, as well as officials from the 
Uganda Ministry of Health. 
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were provided for profit maximizing reasons, i.e., as a way to increase the demand 
for products sold by the CHPs, the findings are also consistent with the view that the 
CHPs also had  nonpecuniary reasons to serve the community and that the pecuniary 
incentives did not (fully) crowd out  nonpecuniary motivations. The findings also add 
to a small but growing literature that investigates the role financial incentives can 
play in motivating individuals engaged in  pro-social activities (Ashraf, Bandiera, 
and Jack 2014; Olken, Onishi, and Wong 2014; and Luo et al. 2015).
To facilitate policymaking, we also perform a  cost-benefit analysis. Our results 
indicate that the average cost per averted death over the three years of study is 
approximately US$4,000. As a comparison, the Guttmacher Institute estimates a 
cost per life saved from expanding a range of health services known to be effective 
at saving lives that is almost three times higher (Perry and Zulliger 2012). Taking 
into account that life expectancy is vastly improved conditional on surviving the first 
few years of life, the estimated average cost per  life-year gained is $68. This fig-
ure compares favorably to existing estimates of various community health interven-
tions, which range from $82 per  life-year gained in expanding maternal and child 
health prevention and promotion activities in Kenya through community health 
volunteers, to about $3,400 per  life-year gained in expanding basic health services 
in Indonesia through village midwives assisted by community health volunteers 
(Borghi et al. 2005, McPake et al. 2015).
The remainder of the paper is organized as follows. Details on the study set-
ting, the research design, and the intervention are presented in Section I. Section II 
reports the main results. In section III, we perform a robustness analysis. Section IV 
presents the  cost-effectiveness estimates, and section V concludes.
I. Intervention and Empirical Design
A. The Program
In 2007, Living Goods (LG), a US based NGO active in Uganda, in collabora-
tion with BRAC Uganda began piloting a new community health delivery model 
intended to improve maternal, newborn, and child health. Unlike  volunteer-based 
community health worker programs, the community health promoter (CHP) pro-
gram harnesses the power of franchised direct selling to provide CHPs with incen-
tives to increase poor households’ access to  low-cost,  high-impact health products 
and basic newborn and child health services. The CHP program was organized into 
geographically based branches, managed by branch managers and supervised by 
the two NGOs (Living Goods and BRAC Uganda). Each CHP was assigned to a 
specific cluster, which in most cases corresponded to a village.
The CHP program is ongoing and by the end of the evaluation period in 2013, 
it was operating in 883 clusters (villages), organized in 29 branches, located in 23 
districts, spread over all 4 regions of Uganda (see Figure 1).3 The program has 
3 Figure A1 in the Appendix provides more detailed images by study district. 
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 continued to expand and by the end of 2018 reached more than 7,000 villages, with 
a total population of over 5.5 million.
The CHPs were selected through a competitive process among female commu-
nity members aged 18 to 45 who applied for the position in each village and who 
possessed basic writing and math skills.4 Eligible candidates received two weeks of 
health and business training, covering preventing, diagnosing, and treating child-
hood illness, recognizing danger signs for referral, healthy pregnancy and newborn 
care, and nutrition.5 At the end of the training, a skills test was administered to 
determine who would become an active CHP. In 2012, the NGOs—independently 
4 Basic characteristics on an average CHP working for the NGO are reported in Appendix Table A1. When com-
paring the CHPs to the average women from the same districts and in a similar age span, as reported in the 2011 
Demographic and Health Surveys (DHS) data, we see that the CHPs are slightly more educated and more likely to 
be the head of household, but similar along all other dimensions. 
5 The specific topics covered in the initial training are: introduction and family health tools; sick child guide 
and malaria, diarrhea, and cough; newborn care; home health care and nutrition; pregnancy and birth; dosage guide 
and mapping; inventory/money management and branch visit; inventory presentations; sales and customer care; 
business tools; team practicum; work preparation and closing activities. 
0 25 50 100 150 200
km
Figure 1. Map of Districts and Distribution of Clusters
Notes: Green  fully colored areas indicate districts that were part of the study, while  cross-hatched areas indicate dis-
tricts excluded from the study, but in which the program was also implemented. Red and blue dots indicate, respec-
tively, control and intervention clusters (villages) included in the study. Figure A1 in the Appendix provides a set of 
more detailed images by study district.
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from the evaluation—surveyed a sample of 196 CHPs working in the study areas 
(not exclusively in the study villages). Appendix Table A2 summarizes the results 
from the  knowledge-related questions that were administered. The average CHP is 
able to detect on average about half of the symptoms and signs related to diarrhea, 
malaria, maternal/neonatal health issues, and pregnancy/birth warning signs. When 
looking at the particular knowledge within each disease, the CHPs score higher on 
the most common signs. These test results confirm that the CHPs are clearly not 
medical specialists, but they are able to detect the most important danger signs at 
some reasonable level and provide key health support for the community. CHPs also 
attended a  one-day refresher training each month to review and refresh key health 
and business topics and to get information on new product and services introduced 
to the program.
The CHPs’ tasks were to conduct home visits to households with children under 
five years old, educate households on essential health behaviors, provide basic med-
ical advice, refer the more severe cases to the closest health center, diagnose illness, 
and sell preventive and curative health products. The CHPs were also instructed to 
visit newborns within the first 48 hours of life and to encourage pregnant women 
to deliver in a facility or with professional assistance. The CHPs received small 
 performance-based incentives to encourage registering of pregnant women and vis-
its of newborns ( ∼ $0.65 per registration/newborn visit).6
The product line the CHPs had at disposal included prevention goods (e.g., insec-
ticide treated bed nets, water purification tablets, and vitamins), curative treatments 
(e.g., oral  rehydration salts, zinc, and artemisinin-based combination therapies 
(ACTs)), as well as other  health-related commodities (e.g., diapers, detergent, and 
hand soap) and durables with potential health benefits (e.g., improved cook stoves, 
solar lights, and water filters). The broad product mix and the pricing strategy had 
three potential benefits: driving up total sales and income for the CHPs; enabling 
the NGOs to  cross-subsidize prices across products; and motivating agents to be 
out visiting households regularly, thanks to the presence of  high-velocity items in 
the product mix.7 The products were sold by the CHP generally below prevailing 
market prices. The retail price was indeed determined by country management with 
a target of keeping prices for preventive and curative products on average 10 percent 
lower than the prevailing local market prices. The CHPs, in turn, purchased these 
products directly from Living Goods or BRAC branches at wholesale prices on 
average 30 percent below market prices and therefore earned an income on each 
product sold.8 The product list (as well as the exact pricing strategy) kept changing 
with the market conditions, but by the end of 2013 it included 152 different prod-
ucts. The average margin for the CHPs (based on the recommended price) across 
6 Similar health services in the public health literature are often labeled as iCCM (integrated community case 
management) and MNCH (maternal, newborn, and child health) services. 
7 The business training received by the CHPs explicitly stressed the importance of building up a  customer-base 
by providing free services like health education, referrals, and newborn visits. 
8 The CHPs were given recommended retail prices, which they were expected to adhere to, although there were 
no strict enforcement policies in place. During field visits, the local branch managers would sometimes ask clients 
about the prices at which products were sold to them or would witness a CHP making a sale. However, we know 
from anecdotal evidence that CHPs sometimes offered discounts or even credit to households in need in order to 
build up a good reputation and a solid customer base within the community. 
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all products was 32 percent. However, when  considering the actual purchases of 
the CHPs, average margin reduces to 20 percent. This suggests that most of the 
sales do not come from products with the highest margins. This is confirmed by 
Figure A2 in the Appendix, which illustrates the average margin the CHPs made 
across 13  macro-categories of products, together with their sales: products that pro-
vide the highest margins are not the most commonly bought by the CHPs. Overall, 
the CHPs operated as  micro-entrepreneurs with financial incentives to meet house-
hold demand and improve child health. The two NGOs also managed to keep their 
own margins at 10 percent at least, by largely buying the products directly from the 
producers, national importers, or national distributors.
On average, CHPs bought products from the NGOs for 150,000 Ugandan shil-
ling ( ∼ $58) per month. With an average margin of 20 percent across the purchased 
products, this resulted to an average earning of roughly $174 per year, or roughly 
32 percent of the average income per capita in Uganda in 2013. CHPs reported ded-
icating an average of 8 hours per week to meetings with households, and the vast 
majority of them had additional sources of income, with the CHP income represent-
ing roughly 50 percent of their total income. However, revenues varied across CHPs, 
due to a combination of population size (or market size) of their catchment area and 
effort put into to the task relative to other income generating opportunities. Figure 
A3 in the Appendix shows the distribution across CHPs of the monthly purchases 
from the NGOs in 2013.
B. Comparison with Traditional Community 
Health Workers and Related Literature
In many developing countries, as is the case in Uganda, the primary strategy 
to extend primary health care from facilities to  underserved rural communities is 
community health workers (CHWs) (Singh and Sachs 2013). In contrast with the 
Living Goods model, traditional CHW programs lack explicit monetary incentives 
(Bhutta et al. 2010, Christopher et al. 2011, Gilmore and McAuliffe 2013, Haines et 
al. 2007, and Perry and Zulliger 2012). Specifically, community health work is often 
voluntary, which given competing opportunities such as  paid work or home pro-
duction, may lead them to devote less time to caregiving. Unsurprisingly, therefore, 
most of the evidence on the positive impact of CHW programs come from studies in 
settings with high quality supervision and support. Such a monitoring system, how-
ever, may not be achievable in routine field situations. How to incorporate incentives 
to motivate CHWs in  large-scale CHW programs, and the impact these programs 
will have, are open questions.
Systematic reviews of existing studies show that CHWs can be impactful in pro-
moting positive health behavior and in providing basic curative and health services 
(Bhutta et al. 2010, Christopher et al. 2011, Gilmore and McAuliffe 2013, Gogia and 
Sachdev 2010, Haines et al. 2007, Lewin et al. 2010, Naimoli et al. 2012, Okwundu 
et al. 2013, and Perry and Zulliger 2012). However, the findings from reviews of ran-
domized controlled trials of CHW programs and  CHW-led interventions are mixed 
(Lewin et al. 2010, Okwundu et al. 2013). Two  proof-of-principle studies cited as 
evidence in the WHO and UNICEF  home-visits strategy statement documented large 
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reductions in neonatal mortality ( 36–54 percent) (Kumar et al. 2008, Baqui et al. 
2008). Five  trials delivered in a program setting documented smaller (15 percent or 
lower)—and in four out of five trials not statistically significant—impact (Darmstadt 
et al. 2010, Bhutta et al. 2011, Bhandari et al. 2012, Kirkwood et al. 2013, Boone 
et al. 2016). Two studies assessed the impact of  community-based training of mothers, 
of which one focused on teaching mothers curative treatments of malaria, finding a 
40 percent reduction in  under 5-years mortality (Kidane and Morrow 2000), and one 
focused on teaching childcare to expectant and postpartum women, finding instead no 
significant impact on neonatal and infant mortality (Sloan et al. 2008). Finally, two 
trials assessed the impact of Integrated Management of Childhood Illness program 
in Bangladesh (Arifeen et al. 2009) and Ethiopia (Amouzou et al. 2016), finding no 
significant effect on  under 5-years mortality. Our study adds to this literature by eval-
uating whether a social entrepreneurial approach to health care delivery can lead to 
significant improvements in children’s health. Although the experimental design does 
not allow us to pin down the specific contribution of the incentives, the results clearly 
indicate that a community health worker program, which embeds financial incentives 
for the health workers, can be highly effective in reducing child mortality.
Our study also contributes to the growing literature on the effect of incentives for 
agents engaged in  pro-social activities. Most literature in this area has focused on 
the education sector and on the impact of performance incentives for teachers (e.g., 
Lavy 2002; Glewwe, Ilias, and Kremer 2010; Muralidharan and Sundararaman 
2011; and Duflo, Hanna, and Ryan 2012). Recently, however, four studies have 
looked at the impact of incentives on the delivery of health services. Within the 
context of rural China, Miller et al. (2012) relied on a randomized trial to study 
the role of incentives for school principals to reduce anemia among their students, 
finding a modest effect.9 In Indonesia, Olken, Onishi, and Wong (2014) studied a 
program that links aid disbursements for health and education to the performance of 
health services, finding significant  short-run improvements in health indicators. In 
Zambia, Ashraf, Bandiera, and Jack (2014) evaluated the effect of both financial and 
 nonfinancial incentives on the performance of agents recruited by a public health 
organization, finding, among other things, that both types of rewards are effective 
when their relative value is high and that the effect is stronger for  pro-socially moti-
vated agents. Finally, within the context of government childcare health workers 
in India, Singh (2015) showed that combining performance pay with information 
provision to mothers leads to a significant reduction in malnutrition, although indi-
vidually the effects are negligible.
Two additional studies, reaching opposite results, study how incentives shape 
community health workers’ performances in sub-Saharan Africa. Ashraf, Bandiera, 
and Lee (2016) experimentally varied the salience of career progression at recruit-
ment stage for a new government health position in Zambia and found that more 
 career-motivated individuals tend to perform better on the job, ultimately leading to 
9 In a new randomized controlled trial, performed in a similar setting, the authors find that large (but not small) 
incentives as well as larger unconditional grants succeed in reducing anemia substantially, with incentives being 
the most  cost-effective solution. The authors also find that performance incentives and unrestricted grants work 
as substitutes, with the larger unconditional grants completely  crowding out the positive effect of incentives (Luo 
et al. 2015). 
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better health outcomes. Deserranno (2019) experimentally varied expected earnings 
at the recruitment stage for new community health promoters in Uganda. Her find-
ings show that when the job is expected to be more lucrative, it attracts less socially 
motivated individuals that tend to perform better on the job, thus ultimately leading 
to worse health outcomes.
C. Study Design and Participants
The study was a  parallel group, stratified cluster randomized controlled trial, 
embedded in the  rollout of the full CHP program. Two hundred and fourteen clusters 
(rural villages) took part in the trial. The clusters were located in 12 geographical 
zones spread across Uganda (see Figure 1). Each zone was associated to a different 
branch of the NGOs. Within each zone, the clusters were randomly divided into 
a treatment group and a control group. In 11 zones out of 12, the randomization 
was balanced (1:1). In 1 zone and for operational purposes the randomization was 
unbalanced (2:1). At least one CHP was assigned to each cluster in the treatment 
group.10 No CHP was assigned to the control clusters. All clusters were enumerated 
at baseline. There were on average 237 households per cluster at baseline.
The main objective of the trial was to assess the impact of having a CHP working 
in the cluster on improving children’s health. The evaluation design and implemen-
tation were independent of program implementation.
The outcomes of interest were measured through a  cross-sectional household 
survey administered between September and December 2013; approximately three 
years after the CHPs began operating in the treatment clusters. Before implementing 
the survey, each cluster was enumerated. A random  computer-generated sequence 
was then used to select 40 households to be surveyed in each cluster (if less than 40 
eligible households were available, all were sampled). The analysis was based on a 
final sample of 7,018 households, and their 11,563  under 5-years children, that have 
lived in the same cluster throughout the trial. The final sample was slightly smaller 
than the  cross-sectional household survey since households that migrated out from 
the baseline cluster were not included in the final analysis, nor were households that 
migrated into the trial clusters during the study period.
Sampled households were visited and asked for written informed consent to par-
ticipate in the survey. The respondent was the female household head if available at 
the time of the interview or the primary female health care giver of the household. 
If neither could be found, or the household refused to participate, a replacement 
household was chosen (this happened in 7.2 percent of the cases, without any sys-
tematic difference between treatment and control clusters). Random  back-checks 
confirmed that the protocol was followed.
The survey was implemented by Innovations for Poverty Action (IPA) Uganda 
with survey teams that were familiar with local customs and spoke the local lan-
guage. Data collectors were masked to whether they were interviewing in a treat-
ment or control cluster.
10 One CHP was assigned to each cluster, with the exception of few large clusters, where two or three CHPs 
were assigned. 
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The trial was embedded in the rollout of the full CHP program (883 clusters) and 
there were no differences in program implementation between the treatment clusters 
(115 clusters) and the 768 clusters that were not part of the trial.
The CHPs were blinded to the trial status of the village they were assigned to 
avoid that the evaluation itself affected the CHPs behavior. As a consequence, no 
surveillance and monitoring system was put in place in the trial clusters and we did 
not track a  predetermined set of households to avoid the CHP focusing their efforts 
on the households that were tracked at the expense of those who were not. Mortality 
rates were calculated based on  cross-sectional household survey data collected at 
the end of the trial, using data from households that had resided in the same cluster 
throughout the trial. To ensure that these households were not systematically differ-
ent in the two assignment groups, we tested for differential in- and  out-migration 
during the trial period and checked for balance across assignment groups using 
 pretrial determined observable household characteristics, and  pretrial infant mortal-
ity rates, collected at the end of the trial period.
All households and especially households with children  under five were potential 
recipients of visits from the CHPs. While the CHPs were recommended to focus 
attention on providing services to households living within their cluster, they were 
not prevented from selling or providing advice also to households outside the clus-
ter, including control clusters. Similarly, households living outside the treatment 
clusters could visit a CHP in a treatment cluster.
Households in both treatment and control clusters could benefit from primary 
health care services provided by other actors, including private clinics, public pri-
mary health dispensaries, and Village Health Teams (a government community 
health worker program).
D. Randomization
Figure 2 describes the trial profile. As the full CHP program was rolled out over 
time, the randomization of clusters was also phased in over time. We began in 2009 
with a sample of 200 clusters (villages) in 10 geographic zones (8 districts). The 
clusters were stratified by zone and size (below or above 400 households) and, within 
each stratum, half of the clusters were assigned to the treatment group and half were 
assigned to the control group through a simple randomization procedure (comput-
erized random numbers) generated by the researchers. In 2010, a year before the 
evaluation began, a decision was taken to only include clusters with less than 400 
households at baseline as the design of the trial was deemed less suitable for clusters 
where the CHPs only would be able to serve a small minority of the households. 
As a consequence, 10 strata with 94 clusters (47 treatment and 47 control) were 
deemed ineligible. Sixty clusters organized in one new geographic zone were added 
in the end of 2010. Half of these 60 clusters were randomly assigned to the treat-
ment group and half were assigned to the control group, following the same proce-
dure adopted for the other zones. An additional zone was added in the beginning of 
2011. For operational purposes, one-third of the 48 clusters in the final zone were 
randomly assigned to the control group and the remaining two-thirds of the clusters 
were allocated to the treatment group. The final sample for the trial thus consisted 
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of 214 clusters (115 treatment and 99 control) in 12 branches/zones (10 districts). 
Concerning the division between the two NGOs, 106 clusters (53 treatment and 53 
control) were in  BRAC-managed areas, while 108 were in  LG-managed areas (62 
treatment and 46 control). The program was fully operational in all treatment clus-
ters in the beginning of 2011. An endline survey was conducted after three years, at 
the end of 2013.
E. Outcomes
The  pre-specified primary outcome was  under-five mortality rate (U5MR). 
Secondary outcomes were infant mortality rate (IMR) and neonatal mortality rate 
(NMR). All mortality rates were calculated using the sample household survey data 
collected at the end of the trial. The household survey recorded detailed birth and 
death information for all children under five living in the households at the time of 
the survey as well as for all children that died under the age of five in the previous 
three years. For each child, we defined the number of month of exposure to the risk 
of death during the trial period, defined as the difference between the birth date of 
the child, or the start date of the trial (January 2011) if the child was born before 
that date, and the date that the child turned five years old if that occurred during 
the trial period, or the date of the endline household survey if the child was less 
than five years old at that time, or the date of the death of the child (see Figure A4 
in Appendix).  Under-5 mortality was then calculated as number of  under-5 deaths 
over the trial period per 1,000  child-years of exposure to the risk of dying under 
the age of five. Infant mortality was calculated as number of deaths during the trial 
period arising within the first year of life per 1,000  infant-years of exposure, with 
 infant-years of exposure calculated in a similar way as the  child-years of exposure 
Sample (2009–2011)
4 provinces
10 districts
12 branches
214 clusters
Enrollment
Allocation
Follow-up (2013)
115 clusters
28,732 households
178,154 estimated population
99 clusters
21,885 households
131,409 estimated population
0 clusters lost to follow-up
23,350 households
3,718 households surveyed
Analysis:
3,228 households
5,371 under-5 children
206 under-5 deaths
0 clusters lost to follow-up
31,097 households
4,401 households surveyed
Analysis:
3,790 households
6,192 under-5 children
183 under-5 deaths
Figure 2. Trial Profile
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to the risk of death. Neonatal mortality was calculated as number of deaths during 
the trial period within the first month of life per 1,000 births.11
Additional secondary outcomes of interest were CHP interactions (to measure 
program coverage), health knowledge,  under-five morbidity, preventive and treat-
ment services, and integrated community case management (iCCM) and maternal, 
newborn, and child health (MNCH) services.12 Data on all secondary outcomes 
were collected in the endline household survey.
F. Sample Size
The sample size was designed to detect a reduction in overall  under-five mortal-
ity. In a  community-based trial in 2009 with significant overlap in the regions cov-
ered to the CHP program studied here, U5MR was 18 deaths per 1,000  child-years 
with a coefficient of variation of the incidence rates of 0.32 (Björkman Nyqvist, 
De Walque, and Svensson 2017). On the basis of these data, and 120  child-years of 
observations in each cluster (i.e., three years and 40 child observations per year), 
a sample size of 214 clusters, of which 115 clusters are allocated to the treatment 
group and 99 clusters to the control group, would detect a 27 percent reduction in 
 under-5 mortality with 80 percent power at the two-sided 5 percent significance 
level.
II. Results
A. Balance at Baseline
Table 1 reports balance tests using  cluster-specific statistics before the program 
begun. There are no statistically different differences between the treatment group 
and the control group in terms of size, household characteristics, and distance to 
main roads, electricity transmission lines, and health facilities.
Household data was not collected at baseline by the research team.13 We there-
fore use endline data to compute infant mortality for the two years preceding the 
intervention, i.e., in 2009 and 2010. Results in Table 2 show that there was no sig-
nificant difference in infant mortality rates between the treatment and control prior 
to the intervention. IMR was 52.4 per 1,000  child-years in the treatment group com-
pared to 50.0 per 1,000  child-years in the control group (  p-value = 0.83).
11 International organizations such as the United Nations and World Health Organization typically express 
mortality in terms of deaths per 1,000 live-births, using data collected over long periods of time and relying on 
a  life-table approach to compute mortality as a probability. For an impact evaluation, when data is collected for 
a relatively short period (three years in our case), a more appropriate approach is to compute mortality as a ratio, 
following the steps described above, and to express it in terms of years of exposure. For completeness and in order 
to facilitate comparisons with other estimates, we also report results obtained using a  life-table approach. 
12 Pneumonia was initially included as a secondary outcome but due to changes in the regulatory environment, 
there was a delay in the authorization to include antibiotics among the list of health products provided by the CHPs 
and we could therefore not study  pneumonia-related outcomes in the end. 
13 Baseline data was collected for most BRAC clusters by BRAC itself. Although the analysis suggests a bal-
anced sample, we do not include it in our discussion, due to its incomplete coverage and to the fact that data were 
collected by one of the implementing agencies. 
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Panel B of Table 2 shows that  the pretrial determined observable household 
characteristics, such as household size at the start of the trial and age and years 
of  education of the household head, were not statistically different between the 
treatment group and the control group for the households used in the analysis, 
i.e., households that had remained in the same cluster throughout the trial and 
surveyed in 2013.
B. Mortality and Morbidity
The primary outcome for the trial was reduction in child mortality. Reduction in 
child mortality links to a wide spectrum of child health specific services and health 
goods that CHPs could provide to households with children under the age of five. 
Specifically, Black, Morris, and Bryce (2003) estimates the distribution of causes of 
death for children under 5 years in  sub-Saharan Africa to be: neonatal disorders (25 
percent), malaria (22 percent), pneumonia (21 percent), diarrhea (20 percent), and 
AIDS (8 percent). Jones et al. (2003) identifies 21 effective child survival interven-
tions, both preventive and treatment approaches, for these causes of deaths, judged to 
Table 1—Baseline Characteristics
Variables Treatment group Control group p-value
Number of clusters 115 99
Households per cluster 250.0 (113) 221.0 (107) 0.226
Households with under-5 children per cluster 86.0 (47) 78.0 (46) 0.665
Distance to main road 5.6 (11.6) 6.8 (12.7) 0.126
Distance to electricity transmission line 1.8 (1.5) 1.8 (1.5) 0.707
Distance to health center 1.4 (1.1) 1.7 (1.2) 0.256
Number of health centers within 5 km 8.3 (5.0) 7.3 (5.2) 0.459
Distance to hospital 10.4 (8.5) 11.1 (8.5) 0.916
Notes: Cells report mean standard deviations across clusters included in the treatment or control group. A variety of 
sources were consulted to generate the dataset, including documents and maps from national utilities, regional power 
pools, and the World Bank. Information on households and households with under-5 children per cluster was collected 
from the enumeration of study villages at baseline. Data for medium and high voltage electricity transmission lines 
were obtained from the Africa electricity transmission network (AICD) study. Health centers takes into account facili-
ties from HCIII (i.e., parish-level health centers, roughly one per 5,000 people) and above. Hospitals refer only to dis-
trict/national hospitals (roughly 1 per 500,000 people). Distance measures are all expressed in kilometers.
Table 2—Baseline Characteristics of Households Not Lost to Follow-Up and Surveyed at Endline
Variables Treatment group Control group p-value
Panel A. Infant mortality
Years of exposure to risk of death under 1 year 1,927 1,743
Deaths under 1 year 101 87
Mortality rate per 1,000 years of exposure 52.4 49.9 0.833
Panel B. Households
Number of households 3,789 3,228
Household size 5.2 (2.4) 5.3 (2.3) 0.590
Age household head 36.4 (12.1) 36.7 (12.4) 0.616
Years of education household head 8.0 (0.2) 8.0 (0.1) 0.122
Notes: Cells report mean standard deviation from endline sample household survey data for households that have 
remained in the cluster throughout the trial, with values scaled back to baseline period.
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be feasible for high levels of implementation in  low-income countries. We measure 
nine of these approaches for which there is sufficient evidence of a causal relationship 
between the intervention and reductions in  cause-specific mortality: six prevention 
approaches (breastfeeding, clean delivery, newborn management, vitamin A supple-
mentation, vaccination, clean water,  insecticide-treated  bed net) and two treatment 
approaches (oral rehydration therapy to treat diarrhea and anti-malarials (ACT) to 
treat malaria). We also measured a number of integrated community case management 
(iCCM) and maternal, newborn, and child health (MNCH) services, which were not 
included in Jones et al. (2003), and where more limited evidence of effect exists. Many 
of these services and goods, including health education, child preventative care, child 
curative care, and the medical drugs related to deworming, malaria, and diarrhea that 
were sold by the CHPs at affordable prices to the households also have the potential to 
affect other health outcomes. We therefore also collected measures of height, weight, 
and hemoglobin levels of all children  under five living in the surveyed households.
We start, in Table 3, to report the findings on child mortality. The first 3 columns 
report the results using the raw data: i.e., the number of  under-5, infant (under 12 
months), and neonatal (under  1-month) deaths per year. In order to assess the impact 
of the program, here as well as in the remaining of the paper, we compare mean 
outcomes after accounting for stratification. That is, we estimate
(1)  Y ij = β T ij +  b j +  ϵ ij ,
where  Y ij is the outcome of interest (e.g., number of  under-five deaths over the study 
period) in village  i , located in the geographical zone associated to the NGO branch 
j ;  T is an indicator variable for villages assigned to the treatment groups,  b j are 
Table 3—Program Impact on Child Mortality
 
Number of deaths
Mortality per 1,000 
years of exposure
 
Mortality per 1,000 births
Under-5
deaths
Infant
deaths
Neonatal
deaths
Under-5
mortality
Infant
mortality
Neonatal
mortality
Under-5
mortality
Infant
mortality
Dependent variable (1) (2) (3) (4) (5) (6) (7) (8)
Program impact −0.58 −0.54 −0.29 −5.95 −18.87 −9.27 −19.86 −17.26
(0.23) (0.19) (0.15) (2.06) (5.94) (4.62) (7.23) (5.35)
Rate ratio 0.73 0.67 0.73
(0.09) (0.09) (0.11)
Mean control 2.08 1.62 1.07 19.4 52.7 33.36 68.4 49.7
Branch FE Yes Yes Yes Yes Yes Yes Yes Yes
Observations 214 214 214 214 214 214 214 214
R2 0.148 0.163 0.162 0.145 0.155 0.135 0.117 0.153
Notes: Program impact measures the coefficient on the assignment to treatment indicator, from a standard OLS 
regression. Dependent variables: (1) number of under-5 deaths; (2) number of infant deaths; (3) number of neona-
tal deaths; (4) number of under-5 deaths per 1,000 child-years of exposure to the risk of death; (5) number of infant 
deaths per 1,000 child-years of infant exposure to the risk of death; (6) number of neonatal deaths per 1,000 births; 
(7) number of under-5 deaths per 1,000 births; (8) number of infant deaths per 1,000 births. Rate ratios in specifica-
tions (4)–(6) are derived from a Poisson model, with branch fixed effects and standard errors clustered by village; 
the number of observations for those specifications are 11,342 (4), 8,808 (5), and 6,499 (6). Branch fixed effects 
are included in every regression. There are 12 branches in the sample. Robust standard errors are in parentheses. R2 
refers to the OLS regressions.
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branch fixed effects, and  ϵ is an error term. In our analysis, we always cluster stan-
dard errors at the cluster/village level, given the likelihood of village level shocks 
and the assignment of treatment at the cluster level.
The first three columns of Table 3 show that the CHP program reduced the num-
ber of deaths in all three age categories. The number of  under-5 deaths dropped by 
28 percent (column 1); the number of infant deaths dropped by 33 percent (col-
umn 2); the number neonatal deaths dropped by 27 percent (column 3). The raw 
data clearly show that the CHP program had a large impact in reducing the number 
of child deaths. However, the reduction in number of deaths may not necessarily be 
driven solely by a reduction in the risk of child death, since cohort sizes may have 
been differentially affected by the intervention due to for example differences in 
fertility rates. Therefore, in columns 4–6 of Table 3, we estimate the mortality rate 
over the period of exposure, i.e., between January 2011 to December 2013.
The estimated rate ratio in column 4, i.e., the incidence of child deaths in the 
treatment relative to the control group, implies that the risk of  under-5 deaths was 
reduced by 27 percent relative to the control group. The effect is of the same order 
of magnitude, and even more precisely estimated, using a linear model—a reduction 
of 5.95 deaths per 1,000  child-years from a control group mean of 19.4 deaths per 
1,000. The reduction in infant mortality (column 5) is even larger—a 33 percent 
reduction in the risk of infant deaths in the treatment versus the control group—and 
even more precisely estimated. Finally, the number of children dying before reach-
ing 1 month ( per 1,000 live births) is 24.1 in the treatment group compared to 33.4 
in the control group and the difference—a reduction of 28 percent in neonatal mor-
tality—is significant at the 5 percent level.
In columns 7 and 8 of Table 3, we also report  under-5 and infant mortality 
expressed in terms of deaths per 1,000 live births. In this case, we estimate the 
probabilities of deaths by using a  life-table approach. Such an approach is more 
appropriate for data spanning longer time periods than the three years we are con-
sidering here. It provides, however, estimates that are more easily comparable with 
other reports of  under-5 mortality. For example, WHO reports  under-5 and infant 
mortality rates for Uganda in 2013 equal to 66.1 and 43.8, respectively (Hug et 
al. 2014). Our estimates for the control group are just slightly higher and equal to 
68.4 and 49.7 deaths per 1,000 live births, respectively. Columns 7 and 8 show that 
the intervention led to a reduction in treatment village of 19.9 deaths in mortality 
 under-5 (28.9 percent reduction) and 17.2 deaths in infant mortality (34.7 percent 
reduction). In both cases, the estimate is significant at 1 percent.
The main outcome of the CHP program was to reduce child mortality at all levels. 
The intervention, however, likely also impacted morbidity and health more gener-
ally. Table 4 reports the results on weight, height, and hemoglobin levels of chil-
dren under 5 years old (panel A), distinguishing impact between children under 
24 months of age (panel B) and children between 24 and 60 months (panel C). 
Weight was measured using portable weighing scales and height using stadiom-
eters. Hemoglobin levels were measured through a hemocue machine.14 Results 
14 A photometer that tests hemoglobin concentration using a single drop of blood taken from the child’s finger. 
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in columns 1 and 2 of Table 4 suggest that the program led to an improvement 
in  height-for-age among children  under 5 years old. The share of stunted children 
according to WHO standards (column 2) in the treatment villages decreased by 1.9 
percentage points, corresponding to a 6.8 percent drop compared to children in the 
control group, and the effect is significant at 10 percent. Similar results are found 
in panel B and C when splitting the sample by age. Results in columns 3 and 4 
show that the program had no detectable effect on wasting. Finally, columns 5 and 
6 show a large and significant improvement in hemoglobin levels, with the share of 
anemic children (i.e., with a hemoglobin level below 10g/dl) in the treatment group 
decreasing by 2.7 percentage points, or by 16 percent compared to average preva-
lence in the control group.
C. Intermediate Outcomes
The community health promoters program was intended to improve child health 
by providing basic curative and preventative health services. Specifically, the CHPs’ 
tasks were to conduct home visits, educate households on essential health behav-
iors, provide basic medical advice, refer the more severe cases to the closest health 
center, visit newborns, and encourage pregnant women to seek antenatal care, as 
well as to sell preventative and curative health products. Some of these tasks were 
directly incentivized, such as the sale of preventative and curative health products 
Table 4—Program Impact on Child Weight, Height, and Hemoglobin Levels
Height-for-age 
z-score
Height-for-age 
z-score < −2
Weight-for-height 
z-score
Weight-for-height 
z-score < −2
Hemoglobin 
level
Hemoglobin 
level < 10g/dl
Dependent variable (1) (2) (3) (4) (5) (6)
Panel A. Children under 60 months
Program impact 0.048 −0.019 −0.005 −0.003 0.128 −0.027
(0.042) (0.010) (0.039) (0.006) (0.041) (0.009)
Mean control −1.166 0.280 −0.022 0.078 11.217 0.169
Observations 10,570 10,570 10,175 10,175 10,568 10,568
Panel B. Children under 24 months
Program impact 0.027 −0.020 0.023 −0.008 0.117 −0.018
(0.058) (0.015) (0.056) (0.010) (0.061) (0.015)
Mean control −1.010 0.280 −0.035 0.115 10.797 0.240
Observations 3,921 3,921 3,755 3,755 3,918 3,918
Panel C. Children 24–60 months
Program impact 0.057 −0.020 −0.023 −0.002 0.147 −0.034
(0.048) (0.013) (0.044) (0.007) (0.045) (0.010)
Mean control −1.255 0.279 −0.015 0.058 11.457 0.128
Observations 6,649 6,649 6,420 6,420 6,650 6,650
Branch FE Yes Yes Yes Yes Yes Yes
Notes: Panel A considers the entire sample of children under five. Panel B only considers children under 24 months 
of age. Panel C only considers children between 24 and 60 months of age. Program impact measures the coef-
ficient on the assignment to treatment indicator. Dependent variables: (1) height-for-age (common measure for 
stunting) expressed in terms of z-scores; (2) indicator for moderately stunted child (z-score < −2); (3) height-
for-age (common measure for wasting) expressed in terms of z-scores; (4) indicator for moderately wasted child 
(z-score < −2); (5) hemoglobin level (common indicator for anemia) expressed in g/dl; (6) indicator for anemic 
child (hemoglobin level < 10g/dl). The z-score records the anthropometric value as a number of standard devi-
ations below or above the reference mean value. Branch fixed effects are included in every regression. There are 
12 branches in the sample. Robust standard errors are in parentheses, clustered at the cluster level. There are 214 
clusters in the sample.
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and  visiting newborns, but the majority of tasks the CHPs were asked to perform, 
including providing health education and health advice in case of sickness, were 
not explicitly incentivized. From a purely profit maximizing perspective, the CHPs 
could still find these tasks worth performing, however, in order to build up repu-
tation and a loyal customer base within the community—a point also emphasized 
in the business training the CHP received. The presence of  high-velocity items in 
the product mix, such as soap, was meant to incentivize CHPs to regularly visit 
households.
We have shown that the program had an impact on the primary outcome—child 
mortality—and we now turn to assessing evidence on intermediate outcomes that 
relates to better child health.
Interaction and Knowledge.—We chose not to have a surveillance or monitor-
ing system in place in the study villages. We therefore cannot directly measure the 
intensity or the quality of the CHPs interactions with the households throughout 
the trial period. Consequently, we base our analysis here primarily on  self-reported 
data from the surveyed households at the end of the trial. However, we have also 
access to complementary information, collected directly by the NGOs, on the 
CHPs’ reported activities. Specifically, Appendix Table A3 shows that the average 
CHP spends roughly 2 days per week working as a health promoter, conducting 10 
household visits per day and working on average 8 hours per week. The CHP revis-
its 13 percent of the households once per month, and 48 percent of the CHPs say that 
they visited a new household in the previous month. The CHPs arrange on average 
1.5 health education meetings per month in their villages.
In Table 5, using household survey data, we assess the quantity, and indirectly, 
quality of the CHPs’ interactions with households. We start by documenting the 
extent of interactions. Column 1 shows that almost 23 percent of the households in 
the treatment clusters had been visited by a CHP in the 30 days preceding the survey. 
While there is evidence of spillovers—5.4 percent of the households in the control 
group have also been visited by a CHP—households in the treatment group were 
more than 4 times as likely to have benefited from such a visit.
In columns 2–7 of Table 5, we assess changes in households’ health knowledge. 
Health education is typically considered as one of the key tasks of community 
health workers and could also be viewed as the first link in a chain linking behav-
ioral changes to improvement in child health outcomes. Health knowledge is also 
relatively easy to quantify and provides insights into the intensity and quality of 
the CHPs’ interactions with the households. As evident, households in the treat-
ment group are better informed about causes and treatments of diarrhea as well as 
about causes for malaria: compared to the control area, they were 11 percent more 
likely to know that diarrhea is transmitted by drinking untreated water; 16 percent 
more likely to know that zinc is effective in treating diarrhea; and 38 percent 
more likely to know that mosquito bites are the only cause of malaria. They were 
also 4.7 percentage points (control mean is 59.1 percent) more likely to have 
heard of food with added vitamins or nutrients. Knowledge about bed nets and 
the importance of professional assistance when giving birth did not differ between 
control and treatment groups, although in these cases there was limited room for 
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 improvement, as even in control villages more than 99 percent of respondents 
displayed such knowledge.
In the last column of Table 5, we report average standardized effects of the health 
knowledge outcomes, i.e., we estimate a seemingly unrelated regression system
(2)  ϒ =  [ I n ⊗ T ] β + μ ,
where  ϒ is a vector of  n related health knowledge outcomes,  I n is an  n by  n identity 
matrix, and  T is a vector of assignment to treatment group indicators. We derive an 
average standardized effect,  β ̃ =  1 _n  ∑ n=1 N  β ˆ n / σ ˆn , where  β ˆ n is the point estimate on 
the treatment indicator in the  n th outcome regression and  σ ˆ n is the standard devia-
tion of the control group for outcome  n (see Kling et al. 2004; Duflo, Glennerster, 
and Kremer 2007). The average standardized effect is positive and highly signifi-
cant, confirming that overall the intervention improved health knowledge among 
households.
Preventive and Treatment Services.—Table 6 presents the findings on the nine 
preventive and treatment approaches we measured and for which there is sufficient 
evidence in the medical literature of a causal relationship between the intervention 
and reductions in  cause-specific mortality. The results for the preventive approaches 
are reported in columns 1–7. For three out of the seven preventive approaches 
we observe a significant difference between the treatment and the control group. 
Households in the treatment group were 5 percent, or 3.8 percentage points, more 
likely to have treated their water before use and their children were 13 percent, or 
5.1 percentage points, more likely to have slept under an  insecticide-treated bed 
net, compared to households in the control group. Households in the treatment 
Table 5—Program Impact on CHP Interaction and Health Knowledge
HH visited 
by a CHP 
in last 30 
days
Diarrhea from 
drinking 
untreated water
Zinc is 
effective 
against 
diarrhea
Mosquito 
bites are the 
only cause 
of malaria
Aware of 
food with 
added 
nutrients
Bed nets 
can help 
prevent 
malaria
Women 
should 
deliver at 
hospital
Average 
standardized 
effect 
(2)–(7)
Dependent variable (1) (2) (3) (4) (5) (6) (7) (8)
Program impact 0.175 0.041 0.036 0.027 0.047 0.001 0.000 0.065
(0.021) (0.012) (0.012) (0.009) (0.016) (0.002) (0.001) (0.014)
Mean control 0.054 0.373 0.227 0.071 0.591 0.991 0.998
Branch FE Yes Yes Yes Yes Yes Yes Yes Yes
Observations 7,018 7,018 7,018 7,018 7,018 6,977 7,018
R2 0.158 0.035 0.084 0.056 0.065 0.005 0.005
Notes: Program impact measures the coefficient on the assignment to treatment indicator. Dependent variables 
are indicators taking value one if: (1) household (HH) was visited by a CHP in the previous 30 days; (2) respon-
dent knows that diarrhea is transmitted by drinking untreated water; (3) respondent believes that zinc is effective 
in treating diarrhea; (4) respondent believes that mosquito bites are the only cause of malaria; (5) respondent has 
ever heard of food with added vitamins or nutrients; (6) respondent believes that bed nets can help prevent catch-
ing malaria; (7) respondent believes a woman giving birth should deliver at a hospital or health facility. Results in 
columns 1 to 7 are obtained from a standard OLS regression. Column 8 reports average (standardized) effect size 
across outcomes (2) to (7), using the seemingly unrelated regression framework to account for covariance across 
estimates. Branch fixed effects are included in every regression. There are 12 branches in the sample. Robust stan-
dard errors are in parentheses, clustered at the cluster level. There are 214 clusters in the sample.
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group with a newborn baby were also 71 percent, or 8.1 percentage points, more 
likely to have received a  follow-up visit in the first week after birth compared to 
households in the control group.15 There is no significant difference between assign-
ment groups in breastfeeding, whether the child was delivered in a clinic, whether 
the child received vitamin A, and whether the child is fully immunized. For three 
of these outcomes, however, there was again limited room for improvement, with 
98 percent of children reported being breastfed, 85 percent of children being deliv-
ered in a clinic, and 91 percent of the children reported being fully immunized.
Columns 8–9 of Table 6 report the results for the two treatment approaches we 
measured: treatment with effective anti-malarials (ACT) in case of malaria, and 
treatment with oral rehydration therapy (ORS) in case of diarrhea.  Self-reported 
morbidity in malaria and diarrhea did not differ between control and treatment 
groups. Conditional on falling sick with diarrhea, children in the treatment group 
15 As expected, the increase is driven by visits from CHPs. See Table A4 in the Appendix for more details. 
Table 6—Program Impact on Preventive and Treatment Services
Child 
delivery 
at HF
Follow-up 
visit first week 
post delivery
Child was 
breastfed
Child took 
vitamin A
Child under 
treated net 
last night
Dependent variable (1) (2) (3) (4) (5)
Program impact 0.010 0.081 −0.005 0.001 0.051
(0.020) (0.020) (0.003) (0.012) (0.014)
Mean control 0.846 0.114 0.985 0.73 0.402
Branch FE Yes Yes Yes Yes Yes
Observations 1,955 1,925 10,953 10,953 10,953
R2 0.054 0.074 0.012 0.006 0.227
Treat water 
before 
drinking
Child fully 
immunized
Child w/diarrhea 
treated 
w/ORS/zinc
Child w/ma-
laria treated 
w/ACT
Average 
standardized 
effect (1)–(9)
Dependent variable (6) (7) (8) (9) (10)
Program impact 0.038 −0.002 0.053 0.004 0.061
(0.015) (0.013) (0.020) (0.015) (0.017)
Mean control 0.774 0.91 0.328 0.668
Branch FE Yes Yes Yes Yes Yes
Observations 7,013 2,041 2,686 5,422
R2 0.190 0.019 0.019 0.016
Notes: Program impact measures the coefficient on the assignment to treatment indicator. Dependent variables are 
indicators taking value one if: (1) the respondent gave birth in a hospital or health facility (HF) (question only asked 
to women that delivered in the previous 12 months); (2) the household received a follow-up visit by a health care 
provider in the first week after delivery (question only asked to women that delivered in the previous 12 months); 
(3) the child (under-5) was breastfed; (4) the child ever took vitamin A; (5) the child slept under a treated bed net the 
previous night; (6) the respondent treats water before drinking it; (7) the child was fully immunized (question only 
asked for children born in the previous 12 months); (8) the child with diarrhea was treated with ORS/zinc (ques-
tion only asked for children that fell sick with diarrhea in the previous 3 months); (9) the child with malaria was 
treated with ACT drugs for (at least) 3 days (question only asked for children that fell sick with malaria in the previ-
ous 3 months). Results in columns 1 to 9 are obtained from a standard OLS regression. Column 10 reports average 
(standardized) effect size across outcomes 1 to 9, using the seemingly unrelated regression framework to account 
for covariance across estimates. Branch fixed effects are included in every regression. There are 12 branches in the 
sample. Robust standard errors are in parentheses, clustered at the cluster level. There are 214 clusters in the sample.
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were 16.2 percent, or 5.3 percentage points, more likely to have received treatment 
with ORS/zinc, column 8; while conditional on falling sick with malaria, children in 
the treatment group were as likely as children in the control group to have received 
treatment with ACTs for at least 3 days, column 9.
Finally, column 10 of Table 6 reports the average standardized effect of the nine 
preventive and treatment approaches. The point estimate is positive and highly sig-
nificant, confirming that overall the intervention increased access or coverage to a 
set of proven medical services.
To what extent can the increased coverage of these services help account for the 
reduction in child mortality? To make some progress in answering this question, we 
use the nine preventive and treatment services in Table 6 as independent variables 
in an Oaxaca decomposition of the child mortality findings between the treatment 
and the control group. The results from such a decomposition are clearly sugges-
tive, not least since the decomposition have a causal interpretation only under a set 
of strong assumptions, but also because there are many potential channels through 
which the CHPs’ activities could reduce mortality, and we do not measure all con-
ceivable channels.16 Keeping those concerns in mind, the Oaxaca decomposition 
suggests that 34 percent of the treatment effect on child mortality can be accounted 
for by differences in means across the nine preventive and treatment services, i.e., 
in changes in the quantity of health service coverage. By contrast, 66 percent can 
be accounted for by differences in coefficients, i.e., by changes in the relationship 
between coverage and mortality, or by other factors that we cannot measure. Our 
preferred interpretation is that this is likely to reflect that the quality of products 
and services provided by the CHPs is higher, compared to what is offered in the 
status quo.17 Further suggestive evidence that this is the case can be seen by running 
regressions of child mortality on all of the nine preventive and treatment services 
jointly, but separately for the treatment and the control group. This analysis indi-
cates that the slope relationships between child mortality and the quantity of these 
services are not the same in treatment and control villages. In particular, in treatment 
villages, each individual coefficient enters with the right sign, consistently implying 
a negative relationship between quantity of these services and child mortality, and 
they are jointly highly statistically significant ( p < 0.001). By contrast, in control 
villages, there is no apparent systematic relationship indicating preventive and treat-
ment services are associated with lower child mortality—the point estimates fluc-
tuate around zero with both positive and negative coefficients—and a test of joint 
statistical significance cannot reject the null hypothesis ( p = 0.14).18
16 A key assumption underlying the decomposition is the ignorability condition, namely that selection on 
observables (in this case with respect to the prevention and treatment measures) is the same in the treatment and 
control group. While this is a weaker condition than the standard zero conditional mean assumption, it is arguably 
a strong one since the presence of a CHP may influence what types of households seek and receive health services. 
For a general discussion of decomposition methods, see Fortin, Lemieux, and Firpo (2011). 
17 One example of improved quality of drugs in the treatment area is Björkman Nyqvist, Svensson, and 
Yanagizawa-Drott’s (2014) study that shows that 37 percent of the local drug outlets in the control areas sell fake 
anti-malarial drugs. Treatment villages are provided higher quality drugs since the CHPs are selling authentic drugs. 
18 We do not include the analysis here, for brevity, but Appendix Figure A5 plots the estimated relationships for 
all nine prevention and treatment services across the two samples. 
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To probe further, we can conduct a simple  back-of-the-envelope calculation 
where we estimate the predicted reduction in child mortality in the control group 
as if the control group had the same coverage as in the treatment group; i.e., same 
means for the nine explanatory variables. The result of such an exercise shows that 
child mortality in the control group is estimated to be reduced from 19.4 to 18.4 
deaths per 1,000 years of exposure, i.e., a predicted reduction of a mere 5.2 per-
cent. Analogously, assuming the treatment group had the same means as the control 
group, predicted mortality in treatment villages is 9.9 percent higher. As a compar-
ison, in the treatment group, child mortality was reduced to 14.2, or by 27 percent 
relative the control group mean. Thus, while this analysis is merely suggestive, it 
indicates that differences in the quantity of life-saving approaches can explain quite 
a bit of the observed mortality effect, but not the bulk of it, whereas the quality by 
which these services were provided seemingly played an important role.
iCCM and MNCH Services.—Community health workers can also improve 
health outcomes through the provision of integrated community case management 
(iCCM) and maternal, newborn, and child health (MNCH) services. Some of these 
services are primarily intended to increase the coverage of effective preventive and 
treatment approaches, including those reported in Table 6. There is limited evidence 
of a direct effect of these services on reducing  under-five mortality from trials deliv-
ered in a program setting. However, it is also the case that most trials in a program 
setting have struggled to achieve significant increases in intervention coverage so as 
to generate measurable reductions in child mortality—a fact that also motivated the 
design of the CHP program evaluated here.19
Table 7 presents the findings on the six iCCM and MNCH services we measured: 
 follow-up visits of children fallen sick in malaria and diarrhea, referrals to profes-
sional care for sick children in malaria and diarrhea, encouragement to give birth 
with professional assistance, and family planning. For all of these services, except 
for referrals to professional care for children reported sick in malaria, we docu-
ment large and significant differences between the treatment and the control group. 
Households with a child  under-5 in the trial areas that fell sick with malaria or 
diarrhea were, respectively, 73 percent and 62 percent more likely to have received 
a  follow-up visit compared to households with sick children in the control areas. 
A 10 percent higher share of women in the treatment group had been advised to 
give birth with professional assistance and 4 percent more of the households in the 
treatment as compared to the control group has used (any form of ) family planning.
The results reported in Tables 6 and 7 also speak to the concern of  multitasking. 
Of the nine preventive and treatment approaches reported in Table 6, five— follow-up 
visit in the first week after birth,  insecticide-treated bed net, clean water, treatment of 
ORS in case of diarrhea, and ACT in case of malaria—were directly incentivized, as 
the CHPs were incentivized to visit newborns and sell water purification tablets and 
insecticide treated bed nets. For four out of these five outcomes, we observe a sig-
nificant difference between the treatment and control groups. For the approaches not 
19 See discussion in Section IB. 
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directly incentivized, there are no significant differences between the groups, but also 
little room for improvement due to high coverage in both groups. Nevertheless, for 
the six iCCM and MNCH services, only family planning was incentivized through 
the inclusion of condoms in the product list. However, we still observe significant 
difference between the treatment and control group in all but one indicator. Overall, 
therefore, the findings suggest that the CHPs acted on the incentives they faced and 
as a result, utilization of a number of  life-saving preventive and treatment services 
increased (see Table 6). But our findings also suggest that child mortality fell not 
only due to the increased coverage of the nine approaches we measure, but also for 
other reasons, including possibly the quality of the services and the products CHPs 
provided. In the end, though, whether the CHPs viewed providing higher quality 
services and/or  non-incentivized services, such as  follow-up visits and referrals 
(results in Table 7) as a way to increase the demand for health products in their port-
folio, or they provided some of these services, and others such as health knowledge 
(results in Table 5) because of  nonpecuniary reasons, we simply do not know. We 
do know, however, that there is no evidence that the intervention led to unintended 
negative health consequences, implying we can rule out more extreme implications 
that could result from the multitasking problems.
III. Robustness
Our study has some limitations. First, the choice not to have surveillance or 
 monitoring systems in place in the study villages implied that we had to rely on 
Table 7—Program Impact on ICCM and MNCH Services
Follow-up 
after child 
sick w/
diarrhea
Child 
w/diarrhea 
referred 
to HF
Follow-up 
after 
child sick 
w/malaria
Child 
w/malaria 
referred 
to HF
Advised 
to deliver 
in HF
Ever used 
family 
planning
Average 
standardized 
effect (1)–(6)
Dependent variable (1) (2) (3) (4) (5) (6) (7)
Program impact 0.043 0.015 0.061 −0.004 0.059 0.025 0.104
(0.017) (0.009) (0.014) (0.008) (0.024) (0.014) (0.026)
Mean control 0.069 0.041 0.084 0.083 0.577 0.683
Branch FE Yes Yes Yes Yes Yes Yes Yes
Observations 2,228 2,687 5,335 5,418 1,942 7,018
R2 0.077 0.008 0.096 0.008 0.039 0.019
Notes: Program impact measures the coefficient on the assignment to treatment indicator. Dependent variables are 
indicators taking value one if: (1) the household received a follow-up visit by a health care provider after a child 
under-5 fell sick with diarrhea (question only asked for children that fell sick with diarrhea in the previous three 
months); (2) the child under-5 sick with diarrhea received a referral to the health facility (HF) (question only asked 
for children that fell sick with diarrhea in the previous three months); (3) the household received a follow-up visit 
by a health care provider after a child under-5 fell sick with malaria (question only asked for children that fell sick 
with malaria in the previous three months); (4) the child under-5 sick with malaria received a referral to the health 
facility (question only asked for children that fell sick with malaria in the previous three months); (5) woman was 
advised to deliver with the assistance of a doctor, nurse, or medical officer (question only asked to women that deliv-
ered in the previous 12 months); (6) respondent ever used family planning. Results in columns 1 to 6 are obtained 
from a standard OLS regression. Column 7 reports average (standardized) effect size across outcomes 1 to 6, using 
the seemingly unrelated regression framework to account for covariance across estimates. Branch fixed effects are 
included in every regression. There are 12 branches in the sample. Robust standard errors are in parentheses, clus-
tered at the cluster level. There are 214 clusters in the sample.
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retrospective recall information. We used standardized data collection methods, and 
any potential recall lapses were expected to affect the treatment and control groups 
equally. The fact that we identify highly statistically significant effects, despite the 
potential measurement error in the dependent variables, brings further credibility to 
our conclusions. Second, as we use the end of trial sample survey to define base-
line residence and thus the core sample for the analysis, selective  out-migration by 
assignment groups could have caused some confounding bias in our main estimates. 
In Table 8, we test whether there was selective in- and  out-migration using enumer-
ation data at baseline and endline combined with data from the household survey.
At baseline, 50,617 households were residing in the trial cluster, 4,132 of whom 
were estimated to have migrated out from the baseline cluster by the end of the 
trial. The average rate of  out-migration per cluster was 7.1 percent (not statis-
tically different between the treatment group and control group ( p = 0.991)). 
An estimated 7,962 households moved into the trial clusters during the study 
period. The average rate of  in-migration per cluster was 15.3 percent (not statis-
tically different between the treatment group and control group ( p = 0.478)). 
The share of sampled households that has moved into the cluster during the trial 
period, out of the total number of sampled households, was not statistically dif-
ferent between the treatment group and control group ( p = 0.614). Hence, mea-
sured in- and  out-migration into the study clusters were similar across assignment 
groups. Moreover, as shown in Table 2, baseline household characteristics of the 
sampled households that had lived in the same cluster for the whole study period 
were not statistically different between the treatment group and the control group. 
Overall, these results indicate that the results are unlikely to be biased by migra-
tion patterns.
Third, the possibility of contamination is plausible because the study clusters, 
within each zone, were geographically close. Analysis of behavioral data (interac-
tion with CHP in the control sites) also suggested that some, although low, contam-
ination occurred, most likely causing us to estimate a lower bound on the impact of 
the CHP program on child mortality.
Fourth, charging for preventive and curative products, even when prices are 
low, could disproportionately benefit the  less-poor households. We therefore study 
whether the impacts of the CHP program differ depending on the wealth of the 
Table 8—Population Data and Flows
Intervention group 
(115 clusters)
Control group 
(99 clusters) p-value
Rate of in-migration 0.16 (0.12) 0.15 (0.11) 0.521
Rate of out-migration 0.07 (0.13) 0.07 (0.13) 0.991
Share of migrants 0.14 (0.09) 0.13 (0.08) 0.614
Notes: Data are mean standard deviations estimated by combining data from baseline census, end-
line census, and endline sample household survey. p-values are adjusted for the stratified random-
ized design. Rate of in-migration is  i j / b j and rate of out-migration is  o j / b j , where  i j =  θ ˆj ×  e j , 
 o j =  b j − (i −  θ ˆj ) ×  e j ,  b j is the number of households residing in cluster j at baseline,  e j is 
the number of households residing in cluster j at endline, and the share of migrants  θ ˆj is an esti-
mate of the share of households in cluster j that moved into the cluster during the trial period, 
out of the total number of households living in the cluster at endline, based on the household 
sample survey. 
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households. One important caveat here is that we only have eight  asset-related 
 variables to use for the wealth index.20 We do not find the impact of the program to 
be stronger in relatively poorer villages. In Figure A6 in the Appendix, we see that 
child mortality was reduced in 9 out of the 12 geographic zones that were part of the 
RCT. When sorting the 12 zones in terms of wealth, the three that did not experience 
any reduction in child mortality rank second, sixth, and tenth.21
However, it might still be the case that within a given village, CHPs focus more on 
the relatively wealthier households, as they might be more likely to purchase more 
products from them. One way to check this is to divide the sample of households 
within each study village in wealth quantiles and run the analysis by quantiles. One 
severe limitation with this approach is that child death is a relatively rare event and 
when we split the sample, results become very sensitive to few extra deaths. This 
problem becomes even more severe when we look at infant and neonatal mortality, 
as the number of deaths decreases further. For this reason, we limit this analysis 
on  under-five mortality. Table A5 in the Appendix shows the results when the sam-
ple is divided in different wealth quantiles. Although the point estimates indicate 
reduction in mortality across the entire wealth spectrum, the results suggest that the 
impact is strongest for households in the middle of the wealth distribution.22
Finally, with the data at our disposal, we can indirectly explore whether and how 
CHPs’ activity is affected by consideration on distance and on household character-
istics. For this analysis we can rely on detailed GPS information that we collected 
during the survey. Results are reported in Table A6 in the Appendix. We find that 
a household is more likely to be visited by a CHP the closer it is to the CHP house 
and the further away it is from the house of Village Health Team (VHT) mem-
bers (although in this case, the results are only weakly significant). We also find 
suggestive evidence that priority households—narrowly defined as households that 
recently experienced a delivery or pregnancy—are more likely to be visited by a 
CHP. Finally, when considering the full sample, we find some evidence of substitut-
ability between different types of community health workers: households in treat-
ment clusters are significantly more likely to interact with CHPs and significantly 
less likely to interact with VHTs.
20 Ownership of durable assets (two sets of clothes for each household member, mobile phone, radio, and 
television), infrastructure and housing characteristics (electricity, roof, and floor material), and consumption habits 
(number of meals containing fish or meat served in a week). 
21 More formally, we observe a negative correlation (−0.73) significant at the 1 percent level between  under-5 
mortality and wealth across control villages. However, we find no clear link between wealth and program impact: 
the correlation between the reduction in mortality and the wealth index is negative (−0.44), but not significant. 
Moreover, if we run a regression with an interaction term between the village treatment status and the average 
wealth in the village, the estimated coefficient on the interaction terms is close to zero and far from being  statistically 
significant. 
22 Important to note is that at the most severe level of poverty, clearly, there must be households who cannot 
afford to buy products from the CHPs. We do not have enough detailed data to investigate whether this is the case 
and if these poor households are not provided any services from the CHPs. We looked at the intermediate outcomes 
by wealth quartiles and we did not observe any clear pattern. For most outcomes, the control group means are lower 
for the poorest quartile, as would be expected, but we still observe increases that are generally of the same order of 
magnitude as in the other wealth quantiles (results available on request). 
178 AMERICAN ECONOMIC JOURNAL: APPLIED ECONOMICS JULY 2019
IV. Cost-Effectiveness Analysis
So far, we have focused on presenting the health impacts of the CHP program. 
We next turn to its cost-effectiveness. Community health worker programs have typ-
ically been promoted as an effective and relatively cheap method to deliver health 
services in low- and  middle-income countries (Dahn et al. 2015). Remarkably, there 
is a dearth of information on the actual  cost-effectiveness of such programs (Bhutta 
et al. 2010, Vaughan et al. 2015). Moreover, when  cost-effectiveness is discussed, 
the impact of the program is often imputed based on a set of assumptions related to 
the coverage of the interventions and their impact (e.g., McPake et al. 2015).23 By 
contrast, we can compute the cost-effectiveness of the CHP program by taking into 
account the actual impact observed in the study.
In estimating cost-effectiveness, we focus on the budget provided by Living 
Goods—one of the two NGOs involved in the project—whose operations exclu-
sively focused on the implementation of the CHP program.24
During the study period, there were an estimated 5,339 children under 5 in the 46 
Living Goods control clusters and 194 of these children died before reaching the age 
of 5. By applying this mortality rate to the 8,306 children located in the 62 Living 
Goods treatment clusters, we should have expected 302 deaths  under-5 in this group of 
villages in the absence of the intervention. Our estimates above indicate that the pro-
gram resulted, on average, in a 27 percent reduction in child mortality, or 81.5 averted 
deaths in the Living Goods treatment clusters over the 3-year trial period.25 Given 
that overall 79 CHPs operated in the Living Goods treatment clusters during the study 
period, we estimate an average of 0.34 deaths averted per CHP per year.
In performing the  cost-effectiveness analysis, we take the perspective of a pub-
lic agency running the CHP program. We therefore take into account the total 
 Uganda-based costs borne by Living Goods, add the deadweight loss associated 
with the increased taxes that would be required to pay the monetary cost of the pro-
gram, and subtract the revenues that were generated by selling the health products 
to the CHPs.26 Table 9 illustrates the evolution of the costs per death averted over 
time, starting in 2010 when Living Goods started its operations in Uganda, under 
the assumption of constant effectiveness of the program. As evident, the analysis 
suggests dramatic improvement in terms of  cost-effectiveness during the first years 
of operations, as new CHPs got added to the program. This is due to the presence of 
23 The Lives Saved Tool (LiST) is a software often used to estimate such effects. LiST estimates how a projected 
change in selected inputs—related to a range of possible health interventions—can translate into a reduction in child 
mortality, for given assumptions on the coverage of and impact of the interventions. 
24 As explained above, the program was run by two NGOs—Living Goods and BRAC. While Living Goods 
only operates the CHP program, BRAC has a vast portfolio of activities. Given the presence of synergies across pro-
grams, it is difficult to properly isolate the portion of costs to be attributed to the CHP program. Still, we obtained 
an estimate of the costs that BRAC attributes to the CHP program and using these cost estimates provides cost- 
effectiveness estimates that are just slightly lower than those discussed in the text. 
25 When splitting the sample between the two NGOs, mortality reduction appears somewhat higher in Living 
Goods clusters, compared to BRAC clusters (31 percent ( p-value = 0.06) versus 23 percent ( p-value = 0.08)), 
but the difference is not statistically significant. 
26 Estimates of the marginal cost of public funds vary considerably. Auriol and Warlters (2012) estimates the 
average marginal cost across 38 African countries to be 1.21. According to their estimates, Uganda is the country 
with the third highest marginal cost, equal to 1.42. We therefore assume the marginal cost of public funds to be 1.42 
(i.e., deadweight loss is 0.42). This is slightly higher than the value typically used for policy analysis (Olken 2007). 
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significant fixed costs (such as the installation of new branches) and economies of 
scale (as for instance staff transportation costs are limited when the program expands 
to villages close to those already served).27 During the first two years, the number 
of CHPs increased by more than 70 percent per year, and cost per averted death 
dropped by more than 50 percent per year. The expansion slowed down in 2013, 
when  cost-effectiveness slightly worsened compared to the previous year.28 Overall, 
in the three years of the evaluation, the average cost per death averted was $4,063.29
As a comparison, the Guttmacher Institute estimates, combining a range of avail-
able  cost-effectiveness estimates, a cost per life saved from expanding a range of 
health services known to be effective at saving lives to $12,000, or almost three 
times higher than the estimate for the CHP program (Perry and Zulliger 2012). 
Overall, however, it is difficult to put the $4,063 estimate in perspective, given the 
lack of estimates of CHW programs based on rigorous evaluations.
A complimentary method to assess cost-effectiveness is to consider how much 
each life saved would have contributed in economic activity over his or her lifetime. 
Dahn et al. (2015), for instance, estimates the net present value of the contribution 
in economic activity that a child  under-5 in SSA will provide over his or her lifetime 
to be approximately $65,000.30 Based on this estimate, the CHP program provides 
an economic return of about 16:1.
27 The fixed cost of opening a new branch office is estimated to be around $12,500 to cover licenses, design, 
furniture, and equipment. The yearly variable costs of an average branch are estimated to be around $19,000, with 
the largest item (about 38 percent) being staff travel expenses. 
28 From conversations with the NGO, costs in 2013 increased for two reasons. First, it was an important expan-
sion year for the NGO, with a number of new hires in key positions and new investments. Among other things, the 
NGO also started its operations in Kenya, and while  Kenya-based costs are not included in the figure, this expansion 
had some repercussions also on the organization in Uganda. Secondly, figures in 2013 also include part of the costs 
used to support the activity of a partner organization. Unfortunately, it is not possible to clearly identify and exclude 
those costs from the budget. 
29 We also obtained an estimate of the total costs attributable to the CHP program in 2013 from BRAC. Overall, 
total costs equal $823,363, while sales revenues were equal to $418,537. Taking into account the deadweight loss 
and the fact that BRAC had 644 CHPs operating in 2013, the estimated  cost-effectiveness for BRAC in 2013 is 
$3,428, which is just slightly lower than the estimate we obtained for Living Goods for 2013. 
30 The estimate is based on the following assumptions: GDP  per capita $1,738, expected GDP  per capita growth 
of 2.5 percent per annum, child will enter the workforce at age 18 and exit the workforce at age 56, and discount rate 
of 5 percent to calculate the net present value of the future  cash flows from projected lifetime earnings. 
Table 9—Cost-Effectiveness Analysis
Year 2010 2011 2012 2013
Total costs (US dollars) 362,853 419,190 476,815 729,653
Deadweight loss (US dollars) 152,398 176,060 200,262 306,454
Sales revenues (US dollars) 87,939 180,936 253,762 407,364
Number of CHPs 128 223 437 477
Estimated number of deaths averted 44 76 149 162
Estimated number of life-years saved 2,589 4,511 8,841 9,650
Cost per death averted (US dollars) 9,819 5,464 2,849 3,877
Cost per life-year saved (US dollars) 165 92 48 65
Notes: Figures are based on the yearly budgets provided by Living Goods, one of the two 
NGOs that implemented the program.
180 AMERICAN ECONOMIC JOURNAL: APPLIED ECONOMICS JULY 2019
In Table 9, we also report the cost of the program per  life-year saved. The esti-
mates assume a life expectancy at age 5 to be equal to 59.5, in line with the 2013 
WHO figures for Uganda. Our figures compare favorably to most existing estimates, 
which range from $82 per  life-year gained in expanding maternal and child health 
prevention and promotion activities in Kenya by relying on  community-health volun-
teers, to $3,396 per  life-year gained in expanding basic health services in Indonesia 
by relying on village midwives assisted by community health volunteers (Borghi 
et al. 2005, McPake et al. 2015). While cost per life saved or per  life-year gained 
are commonly used metrics to assess the cost-effectiveness of a health intervention, 
there are additional dimensions that could be taken into account when considering 
the welfare impact of the program. For instance, the fact that the program allows 
households to rely on primary  health care in their own village, instead of traveling 
far to reach a health facility, is likely to bring a range of benefits to the society: it 
lowers the time and transportation costs for the patients,31 while also reducing the 
workload of the health facilities, freeing up resources that can be better used for 
more urgent cases. Moreover, the presence of financial incentives provides all CHPs 
and their families with an additional source of income.
As the program keeps expanding, reaching more villages and recruiting more 
CHPs, the costs per CHPs are expected to decrease even further, making the pro-
gram even more  cost-effective.
V. Conclusion
We estimate that the CHP program in Uganda reduced  the under-five mortality 
rate by 27 percent, infant mortality rate by 33 percent, and neonatal mortality rate 
by 27 percent after three years. These effects are supported by changes in health 
knowledge, increased utilization of preventive and treatment approaches, as well as 
increased maternal, newborn, and child health service coverage. We also estimate 
the  cost-effectiveness of the program and find the estimated cost per averted death 
 under five years old during the study period to be approximately $4,000.
While a growing body of evidence has identified effective interventions that can 
be delivered by community health workers, a key consideration for the success and 
sustainability of such program is how  high-quality performance by community 
workers can be achieved and maintained. This study is the first impact evaluation of 
a community health delivery intervention based on an incentivized approach. Unlike 
previous studies that have primarily focused on the impact of specific interventions 
that could be delivered effectively in a community setting, our focus is on how to 
ensure that community health workers successfully implement a set of interventions 
proven to be effective if delivered and the impact that may have on child health.
In the CHP program, community health workers operated as  micro-entrepreneurs 
earning an income on the sale of preventive and curative products. A concern with 
such a scheme is that it may encourage overuse of medications and  inappropriate 
31 By exploiting a randomized evaluation of spring protection in Kenya, Kremer et al. (2011) estimate the aver-
age value of time to be about 7 percent of the mean local hourly wage. In the context of Mozambique, Jeuland et al. 
(2010) estimate the opportunity cost of time to be approximately 28 percent of the mean hourly wage. 
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treatment at the expense of prevention and referrals. However, the provision of free 
services like health education and  follow-up visits was viewed as strategy to build up 
a loyal customer base. More generally, whether extrinsic incentives in some domains 
have positive or negative impacts on intrinsic motivation in other domains is an 
empirical question. The data do not suggest that the program only had an impact on 
incentivized services, with evidence of increases in the promotion of healthy behav-
ior and improved health knowledge. More specifically, while we document large 
increases in some incentivized tasks, like visits of newborns, we also document 
large increases for tasks that were not directly incentivized, such as  follow-up visits 
of children sick in malaria and diarrhea. Although the experimental design does not 
allow us to clearly separate out the mechanisms, the findings suggest that providing 
financial incentives on one dimension of the desired CHP behavior did not crowd 
out the allocation of effort into other margins.
Our analysis has shown no significant impact on malaria prevalence and  treatment. 
However, a similar treatment pattern does not necessarily imply a  similar quality of 
treatment. Among other things, the CHPs sell authentic ACT drugs. There is growing 
evidence that the private market for anti-malarial medicines is plagued by counterfeit 
and substandard (fake) products, with recent estimates suggesting that as much as 
a third of the anti-malarial drugs sold contain too little or no active pharmaceutical 
ingredients (Nayyar et al. 2012). Uganda is no exception: a smaller study conducted 
in the same research areas one year into the program estimated that 37 percent of 
the retail outlets were selling substandard anti-malarial drugs (Björkman Nyqvist, 
Svensson, and Yanagizawa-Drott 2013). Poor quality is not specific to ACTs but 
is a generic problem in the largely unregulated market for preventive and curative 
health products in many developing countries. The CHPs market share for ACT 
drugs and ORS were 11.3 percent and 14.1 percent, respectively. Under the assump-
tion that every third dose of ACT treatment sold in the private market is fake and 
that  authentic drugs are provided in the public sector (about 40 percent of the market 
share), children in the treatment group are 19 percent less likely to be treated with 
a fake ACT medicine.
With the accumulated  know-how we have today, few would question the 
 potential of community health care provision. How to best ensure that CHW 
deliver timely and appropriate services is, however, largely an open question and 
motivates the continued search for innovative approaches. The CHP program we 
studied here harnesses the power of franchised direct selling ( business-in-a-bag) 
to provide community health providers with incentives to increase access to 
 low-cost,  high-impact health products and basic newborn and child health  services. 
As of the end of 2018, the program was active in more than 7,000 clusters, with a 
total population of over 5.5 million. The impact of the CHP program was condi-
tional on existing facility based professional health care as availability of referral 
 services is a crucial component to the program. Thus, the findings should encour-
age  government and  nongovernment organizations to continue improving their 
 facility based care, but also points to the importance of integrating the program 
into the existing health service provision strategy. The process of integrating 
the CHP program we have evaluated here into the overall health care system is 
 currently underway.
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Appendix
Table A2—CHPs’ Knowledge
Topic Percent correct answers
Diarrhea 30.1
Malaria 68.9
Maternal and neonatal health 43.2
Pregnancy/birth warning signs 45.1
Notes: Figures are taken from the report “Assessment of Activities by the Community Health 
Promoters of BRAC and Living Goods in Uganda” produced by BRAC and Living Goods in 
2012. The sample covers 196 CHPs working in the study area. Scores for Diarrhea are based 
on ability to detect signs and symptoms, correct treatment, prevention, and what to do when 
identifying someone with the disease. Scores for Malaria are based on detecting signs and 
symptoms, correct treatment, prevention, what to do when identifying someone with malaria, 
and correct dosage of ACT to children under the age of two and five. Scores for Maternal and 
neonatal health are based on detecting signs and symptoms of pregnancy, danger signs during 
pregnancy, what drugs to use when treating malaria, what to do when identifying a pregnant 
woman, what to do when identifying a woman near to giving birth, and what to do when there 
is a newborn in the home. Scores for Pregnancy/birth warning signs are based on detecting 
hemorrhage, convulsions/seizures, prolonged labor, obstructed labor, severe headache, blurred 
vision, hyperpyrexia, and water breaks without labor starting. 
Table A1—CHWs’ Characteristics
Personal characteristics CHP women DHS women
Age 37.4 36.4
Married 75% 77%
Respondent is head of household 67% 29%
Number of household members 7.5 6.1
Number of children (0–5) 1.8 1.1
Have children under age 5 67% 68%
Have school children (age 6–18) 89% 94%
Years of education 9.5 6.1
Finished O-level education 43% 32%
Previous experience as health worker 29% NA
Electricity in the household 5%1, 59%2 11%1, 53%2
Brick home 26%1, 73%2 67%1, 75%2
Notes: Figures are taken from the report “Assessment of Activities by the Community Health 
Promoters of BRAC and Living Goods in Uganda” produced by BRAC and Living Goods in 
2012. The sample covers 196 CHPs working in the study area. The DHS women sample is 
based on women living in the study districts and in the age span 30–45 (326 observations).
1 Indicates the rural share of people with electricity and brick homes.
2 Indicates the urban share of people with electricity and brick homes.
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Table A3—CHPs’ Activities
Question Average answer
Days per week in visits 2.3
Hours per day in visits 3.4
Household visits per day 10.6
Household visited more than once per month 13.0
Percent CHPs who visited someone new last month 47.9
Number of community health meetings per month 1.4
Average attendance in community health meetings 16.8
Notes: Figures are taken from the report “Assessment of Activities by the Community Health 
Promoters of BRAC and Living Goods in Uganda” produced by BRAC and Living Goods in 
2012. The sample covers 196 CHPs working in the study area. 
Table A4—Program Impact on Health Visits
Follow-up visit...
… first 
week post 
delivery
… after 
child sick 
with malaria
… after child 
sick with 
diarrhea
Average 
standardized effect
Dependent variable (1) (2) (3) (4)
Panel A. Any health care provider
Program impact 0.081 0.061 0.043 0.215
(0.020) (0.014) (0.017) (0.048)
Mean control 0.114 0.084 0.069
Panel B. CHPs
Program impact 0.069 0.057 0.043 0.437
(0.016) (0.013) (0.015) (0.101)
Mean control 0.027 0.011 0.017
Panel C. Any other health care provider
Program impact 0.012 0.005 0.000 0.021
(0.014) (0.008) (0.009) (0.026)
Mean control 0.087 0.073 0.051
Branch FE Yes Yes Yes Yes
Observations 1,925 5,335 2,228
Notes: Program impact measures the coefficient on the assignment to treatment indicator. Dependent variables 
are indicators taking value one if the household received a follow-up visit by a health care provider: (1) in the first 
week after delivery; (2) after a child under-5 fell sick with malaria; (3) after a child under-5 fell sick with diarrhea. 
Panel A considers follow-up visits performed by any health care provider (this includes CHPs, doctors, nurses, other 
health workers, and traditional healers). Panel B restricts the focus to follow-up visits performed by CHPs from 
Living Goods or BRAC. Panel C restricts the focus to follow-up visits performed by any other health care provider. 
Columns 1 to 3 report the results of separate OLS regressions. Column 4 reports average (standardized) effect size 
across outcomes 1 to 3, using the seemingly unrelated regression framework to account for covariance across esti-
mates. Branch fixed effects are included in every regressions. There are 12 branches in the sample. Robust standard 
errors are in parentheses, clustered at the cluster level. There are 214 clusters in the sample.
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Table A6—CHPs’ Activity
Treatment clusters Full sample
Ever interacted with
HHs ever visited by a CHP HHs visited by a CHP in last 30 days CHP VHT
Dependent variable (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
Distance −0.061 −0.064 −0.037 −0.041
 from CHP (0.017) (0.019) (0.018) (0.021)
Distance 0.042 0.045 0.029 0.029
 from VHT (0.023) (0.021) (0.030) (0.021)
Priority HH 0.054 0.045
(0.015) (0.014)
Program impact 0.215 −0.032
(0.025) (0.015)
Branch FE YES YES YES YES YES YES YES YES YES YES
Number of clusters 104 104 95 115 104 104 95 115 214 214
Observations 3,434 3,431 3,138 3,790 3,434 3,431 3,138 3,790 7,018 7,018
R2 0.307 0.297 0.312 0.294 0.190 0.182 0.191 0.182 0.098 0.178
Notes: Dependent variables are indicators taking value one if: (1)–(4) households were ever visited by a CHP; (5)–(8) 
households were visited by a CHP in the previous 30 days; (9) households interacted with a CHP at any point in 
time for any health-related issue (including receiving advice or medical products); (10) households interacted with 
a VHT at any point in time for any health-related issue (including receiving advice or medical products). In col-
umns 1 to 8, the sample is restricted to villages in treatment areas (115 clusters and 3,790 households). Clusters in 
which the geolocation of the CHP or of the VHT could not be recorded are missing. Priority households are defined 
as households where a woman delivered in the previous six months and/or a woman is currently pregnant. Program 
impact measures the coefficient on the assignment to treatment indicator. Robust standard errors are in parentheses, 
clustered at the cluster level. 
Table A5—Under-5 Mortality by Wealth Quantiles
Under-5 mortality per 1,000 years of exposure
50–50 split Quartiles
Poorest Richest
Poorest
quartile Others
Richest
quartile Others(1) (2) (3) (4) (5) (6)
Program impact −5.67 −6.14 −4.40 −6.81 −5.90 −6.12
(2.95) (2.90) (3.83) (2.38) (4.38) (2.26)
Rate ratio 0.78 0.68 0.83 0.69 0.69 0.74
(0.12) (0.12) (0.18) (0.10) (0.16) (0.10)
Mean control 19.84 18.77 18.83 19.93 20.41 19.24
Branch FE Yes Yes Yes Yes Yes Yes
Observations 214 214 214 214 214 214
R2 0.082 0.124 0.045 0.150 0.047 0.126
Notes: Program impact measures the coefficient on the assignment to treatment indicator, from 
a standard OLS regression. The dependent variable is the number of under-5 deaths per 1,000 
child-years of exposure to the risk of death. Rate ratios are derived from a Poisson model, with 
branch fixed effects and standard errors clustered by village. Each regression refers to a dif-
ferent sample, selected on the basis of a wealth index, computed using Principal Component 
Analysis (PCA) on eight variables capturing ownership of durable assets (two sets of clothes 
for each household member, mobile phone, radio, and television), infrastructure and hous-
ing characteristics (electricity, roof, and floor material), and consumption habits (number of 
meals containing fish or meet served in a week). In columns 1 and 2, the sample is divided 
within each village between the poorest and the richest halves. In columns 3 to 6, the sam-
ple is divided within each village in wealth quartiles: column 3 considers the poorest quartile; 
column 4 considers the other three quartiles (excluding the poorest one); column 5 considers 
the richest quartile; column 6 considers the other three quartiles (excluding the richest one). 
Branch fixed effects are included in every regression. There are 12 branches in the sample. 
Robust standard errors are in parentheses. R2 refers to the OLS regressions.
VOL. 11 NO. 3 185BJÖRKMAN ET AL.: REDUCING CHILD MORTALITY IN THE LAST MILE
Panel A. Arua district
Panel C. Jinja district Panel D. Mbale district
Panel E. Mpigi district Panel F. Mukono district
Panel G. Pallisa district Panel H. Ibanda (North)/Mbarara (South) district
Panel B. Bushenyi (West)/Sheema (East) districts
Figure A1. Maps by Study District
Notes: These figures are expansions of the map reported in Figure 1. Green  fully colored indicate districts that were 
part of the study. Red and blue dots indicate, respectively, control and intervention villages included in the study.
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Figure A2. Yearly CHP Purchases and Margins across Products
Notes: The figure illustrates the average margin the CHPs made across 13  macro-category of products (152 different 
products in total) in 2013, together with the amount they purchased from the local branches in 2013.
Figure A3. CHP Monthly Purchases
Notes: The figure illustrates the kernel distribution across CHPs of the monthly purchases from the NGOs in 2013. 
Values range from 0 to 950,000 UGX (mean: 150,000; standard deviation: 140,000). Information was provided by 
the two NGOs, Living Goods and BRAC.
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Jan 2011
Child 3
Child 2
Child 1
End lineA B C D
Figure A4. Computation of the Months of Exposure to the Risk of Death  Under-5
Notes: For each child, the number of months of exposure to the risk of death  under-5 during the study period is com-
puted as the number of months between the birth date of the child, or the start date of the program (January 2011) if 
the child was born before that date, and the date that the child turned five years old if that occurred during the study 
period, or the date of the end line household survey if the child was less than five years old at that time, or the date 
of the death of the child. The figure illustrates these different possibilities using the example of 3 children: child 1 
was born before January 2011 and turned 5 at time C (the same computation would hold if the child died under age 
5 at time C). Hence, the exposure to the risk of death  under-5 for child 1 is represented by the (rounded) number 
of months between January 2011 and time C. Child 2 was instead born at time A, during the study period, but died 
at time D. Hence, in this case, the exposure to the risk of death  under-5 is represented by the (rounded) number of 
months between time A and D. Finally, child 3 was also born during the study period, at time B, and was still alive 
at the time of the end line. In this case, the exposure to the risk of death  under-5 is represented by the (rounded) 
number of months between time B and the time of the end line survey.
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Figure A5. Correlations between Child Mortality and Intermediate Outcomes
Notes: The two graphs above plot the slope relationships between child mortality and the nine preventive and treat-
ment services, separately in treatment and control villages. For ease of interpretation, all variables are standard-
ized in the full sample. The underlying variation consists of the residuals from a regression of child mortality on 
all the nine variables jointly, and thus each slope captures the residual relationship holding constant the other eight 
variables. The graph shows that in treatment villages, all nine relationships are negative ( joint  p-value < 0.001), 
implying that greater coverage of the prevention and treatment services are associated with lower mortality; whereas 
in control villages, there is no apparent systematic relationship ( joint p = 0.14). Our preferred interpretation is 
that these relationships indicate that not only quantity, but also quality, of these services matters and that the quality 
of services provided by the CHPs was greater compared to the status quo.
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